14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session IX. Novel compounds targeting inflammatory <strong>signaling</strong> pathways Poster IX, 2<br />

NAC prevents cardiac maladaptative responses to hypertension <strong>and</strong> promotes TNFR-2<br />

<strong>signaling</strong> in cardiomyocytes<br />

Nicole Defer1, Gabriele C<strong>and</strong>iani1, Jin-Bo Su2, Marie B<strong>our</strong>raindeloup2, Luc Hittinger2,<br />

Françoise Pecker1 <strong>and</strong> Catherine Pavoine1<br />

1INSERM U581; Université Paris 12, Faculté de Médecine; Créteil, F-94000 France;<br />

2INSERM U660; Université Paris 12, Faculté de Médecine; Créteil, F-94000 France;<br />

The aim: Our previous in vivo studies showed that N-acetylcysteine (NAC) was a potential<br />

therapeutical tool for the management of hypertension–induced heart failure. However, early<br />

mechanisms of NAC action remained to be defined.<br />

Results <strong>and</strong> Methods: Rats were given a f<strong>our</strong> week treatment with the nitric oxide synthase<br />

inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 50 mg/kg/day in drinking water) <strong>and</strong><br />

high salt diet (HS, 8% NaCl). HS/L-NAME rats displayed hypertension-induced adaptative<br />

responses, characterized by thickening of ventricular walls <strong>and</strong> eccentric hypertrophy of<br />

cardiomyocytes, without left ventricular dysfunction. This was associated with changes in two<br />

early biochemical markers of adaptative cardiac responses, namely decrease in beta-1adrenergic<br />

(AR) stimulation of adenylyl cyclase (AC) <strong>and</strong> increase in the number of the type<br />

1 TNF receptors (TNFR-1) over TNFR-2. NAC treatment (125 mg/kg/day in drinking water)<br />

given during weeks 3 <strong>and</strong> 4 of HS/L-NAME administration, had no effect on hypertension,<br />

but triggered a proportional hypertrophy of cardiomyocytes <strong>and</strong> prevented alterations of both<br />

beta-1-AR/AC <strong>signaling</strong> <strong>and</strong> TNFR-1/TNFR-2 ratio. Imaging studies performed on<br />

electrically stimulated cardiomyocytes isolated from control rats treated for 2 weeks with<br />

NAC, showed that NAC blunted TNF- induced production of ROS <strong>and</strong> its associated negative<br />

effect on Ca transient amplitude. Neutralizing anti-TNFR-1 antibodies mimicked these effects<br />

of NAC in cardiomyocytes isolated from control untreated rats. Furthermore, NAC<br />

uncovered a strong enhancing effect of TNF on Ca transients, that was associated with<br />

phosphorylation of Erk, Akt <strong>and</strong> PKC zeta <strong>and</strong> activation of the cPLA2. These TNF effects<br />

were impaired by anti TNFR-2 antibodies.<br />

Conclusion: Our results highlighted NAC as a tool fav<strong>our</strong>ing TNFR-2 while blunting TNFR-1<br />

<strong>signaling</strong> pathways, <strong>and</strong> counteracting early maladaptative responses to hypertension.<br />

- 326 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!